Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Keros Therapeutics Inc
(NQ:
KROS
)
45.70
+0.63 (+1.40%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Jun 28, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
1,192,703
Open
45.10
Bid (Size)
27.66 (3)
Ask (Size)
48.95 (21)
Prev. Close
45.07
Today's Range
44.22 - 46.32
52wk Range
27.02 - 73.00
Shares Outstanding
23,337,862
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Analyst Sees Keros Therapeutics As Next Acceleron, Set For Major Biotech Growth
June 25, 2024
Keros Therapeutics is advancing novel therapies for hematological and cardiopulmonary disorders via TGF-β signaling regulation. Oppenheimer rates KROS Outperform with a $102 price target.
Via
Benzinga
KROS Stock Earnings: Keros Therapeutics Beats EPS for Q1 2024
May 08, 2024
KROS stock results show that Keros Therapeutics beat analyst estimates for earnings per share the first quarter of 2024.
Via
InvestorPlace
Performance
YTD
+5.96%
+5.96%
1 Month
-2.18%
-2.18%
3 Month
-31.68%
-31.68%
6 Month
+14.94%
+14.94%
1 Year
+14.62%
+14.62%
More News
Read More
Keros Therapeutics Inc. (NASDAQ: KROS) Near the Top of Equities by Percentage Gain on 1/4
January 04, 2024
Via
Investor Brand Network
Why Mobileye Global Shares Are Trading Lower By Over 23%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
January 04, 2024
Via
Benzinga
Where Keros Therapeutics Stands With Analysts
July 26, 2023
Via
Benzinga
Recap: Keros Therapeutics Q1 Earnings
May 04, 2023
Via
Benzinga
Recap: Keros Therapeutics Q3 Earnings
November 03, 2022
Via
Benzinga
Lamb Weston Posts Upbeat Results, Joins Omega Therapeutics, Allstate And Other Big Stocks Moving Higher On Thursday
January 04, 2024
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Why bluebird bio Shares Are Trading Higher? Here Are Other Stocks Moving In Monday's Mid-Day Session
December 11, 2023
Via
Benzinga
Keros Therapeutics Posts Preliminary Data Early-Stage KER-012 Trial
May 18, 2022
Via
Benzinga
Keros Therapeutics Posts Encouraging Preclinical Data Of RKER-012 In Type Of High Blood Pressure
May 18, 2022
Via
Benzinga
Coinbase, Riot Platforms, Marathon Digital And Other Big Stocks Moving Lower On Monday
December 11, 2023
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Benzinga's Top Ratings Upgrades, Downgrades For July 31, 2023
July 31, 2023
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For July 26, 2023
July 26, 2023
Via
Benzinga
Why American Software Shares Are Trading Lower By Over 20%? Here Are Other Stocks Moving In Friday's Mid-Day Session
June 09, 2023
Via
Benzinga
Why Shares of Keros Therapeutics Jumped This Week
April 21, 2023
Via
The Motley Fool
Benzinga's Top Ratings Upgrades, Downgrades For February 14, 2023
February 14, 2023
Via
Benzinga
BioMedNewsBreaks – Keros Therapeutics Inc. (NASDAQ: KROS) Presents Clinical and Preclinical Data from Its Lead Hematological Programs at 64th ASH Event
December 13, 2022
Via
Investor Brand Network
Benzinga's Top Ratings Upgrades, Downgrades For October 18, 2022
October 18, 2022
Via
Benzinga
Why Shares of Keros Therapeutics Rose 10.2% This Week
October 14, 2022
Via
The Motley Fool
Alphatec Holdings, Immatics And Some Other Big Stocks Moving Higher On Monday
October 10, 2022
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For July 26, 2022
July 26, 2022
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
May 18, 2022
Via
Benzinga
Stocks That Hit 52-Week Lows On Thursday
June 23, 2022
Via
Benzinga
76 Biggest Movers From Yesterday
May 19, 2022
Via
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.